Duo Oncology
www.duooncology.comRight now, 60-80% of patients show little response to standard immunotherapy or chemotherapy. Duo Oncology plans to transform patient outcomes with a new type of nanotherapy.
Read more
Right now, 60-80% of patients show little response to standard immunotherapy or chemotherapy. Duo Oncology plans to transform patient outcomes with a new type of nanotherapy.
Read more
Country
State
Pennsylvania
City (Headquarters)
Pittsburgh
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(10)
Reach decision makers at Duo Oncology
Free credits every month!
Duo Oncology FAQ
Pittsburgh, United States
Biotechnology Research
